|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.03 USD | +1.80% |
|
+5.93% | +4.31% |
| 12:04am | OPKO Health Raises $250 Million Non-Dillutive Capital Via Note Issue | MT |
| 07-17 | Pfizer Inc. and Valneva SE Announce Primary Vaccination Series Completion | CI |
Pfizer Inc. (NYSE:PFE) is reportedly in talks to buy ACADIA Pharmaceuticals Inc. (NasdaqGS:ACAD) for $44 per share. Acadia Pharmaceuticals (NASDAQ:ACAD) is currently higher by 9%. The buyout talks have often centered around Acadia, but it has been a while since its stock saw such a big intraday move behind acquisition chatter.
The rumor first broke on Twitter when a well-respected twitter personality known as Option Runners took the rumor and put it on blast.
| 1st Jan change | Capi. | |
|---|---|---|
| +4.31% | 167B | |
| +55.35% | 848B | |
| +31.64% | 627B | |
| -0.10% | 363B | |
| +15.47% | 318B | |
| +13.10% | 299B | |
| +15.51% | 243B | |
| +16.72% | 225B | |
| +16.54% | 179B | |
| +2.52% | 125B |
PFIZER, INC. 
